ICICI shares dip on Russian exposure worry
MUMBAI (Reuters) - Shares in ICICI Bank fell 4 percent on Wednesday on concerns the bank's Russian assets may be vulnerable as firms there struggle to stay afloat.
ICICI shares were down 12.1 rupees at 284.30 rupees in a Mumbai market that was off 0.1 percent in the afternoon. The stock dropped to just above last October's low of 282.15 rupees, a break of which would take it to its lowest in nearly 4-½ years.
"The market is very concerned over the Russian exposure. Investors are expecting sharp write-downs as firms there are failing," said Amitabh Chakraborty, president for equities at Religare Securities.
The stock is down more than a third this year. It tumbled 21.2 percent in February and has seen more losses in March. Its market capitalisation has fallen to below that of smaller private-sector rival HDFC Bank.
"There are no losses in Russia," an ICICI spokesman said, but declined to put a value to the Russian assets.
Brokerage CLSA said in a recent note the Russian exposure under ICICI Bank Eurasia was $584 million, consisting largely of loans to customers and placements with banks.
The subsidiary was formed in 2005 after the Indian bank bought Russia's Investitsionno-Kreditny Bank.
The Russian operations do not have a meaningful deposit franchise and group companies fund 84 percent of the liabilities, CLSA said.
Last year, the management of NYSE-listed ICICI had to repeatedly assure investors and depositors after its exposure to collapsed Lehman Brothers triggered a slump in its share price.
- Tweet this
- Share this
- Digg this
- Wal-Mart and allies in face-off with Apple Pay over mobile payments
- Hundreds of Iraqi tribesmen opposed to Islamic State found in mass graves
- India's universal healthcare rollout to cost $26 billion
- PM Modi boots officials out of the first class cabin
- Sensex, Nifty hit record highs, shrug off Fed's hawkish tone
India's universal health plan that aims to offer guaranteed benefits to a sixth of the world's population will cost an estimated 1.6 trillion rupees ($26 billion) over the next four years, a senior health ministry official said. Full Article